Caxton Associates LLP Acquires Shares of 46,284 Lemonade, Inc. $LMND

Caxton Associates LLP acquired a new stake in shares of Lemonade, Inc. (NYSE:LMND) in the first quarter, Holdings Channel reports. The firm acquired 46,284 shares of the company’s stock, valued at approximately $1,455,000.

Other large investors have also added to or reduced their stakes in the company. The Manufacturers Life Insurance Company raised its stake in Lemonade by 7.7% during the fourth quarter. The Manufacturers Life Insurance Company now owns 31,000 shares of the company’s stock valued at $1,137,000 after buying an additional 2,209 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Lemonade by 35,901.8% in the first quarter. GAMMA Investing LLC now owns 19,801 shares of the company’s stock worth $630,000 after purchasing an additional 19,746 shares during the last quarter. Northern Trust Corp raised its stake in shares of Lemonade by 23.7% in the fourth quarter. Northern Trust Corp now owns 562,502 shares of the company’s stock worth $20,633,000 after purchasing an additional 107,592 shares during the last quarter. Halter Ferguson Financial Inc. raised its stake in shares of Lemonade by 62.8% in the first quarter. Halter Ferguson Financial Inc. now owns 476,764 shares of the company’s stock worth $14,985,000 after purchasing an additional 183,974 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of Lemonade by 3.6% in the first quarter. Nisa Investment Advisors LLC now owns 11,020 shares of the company’s stock worth $346,000 after purchasing an additional 380 shares during the last quarter. Hedge funds and other institutional investors own 80.30% of the company’s stock.

Insider Buying and Selling at Lemonade

In related news, COO Adina Eckstein sold 5,000 shares of Lemonade stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $49.00, for a total value of $245,000.00. Following the completion of the sale, the chief operating officer owned 189,653 shares of the company’s stock, valued at $9,292,997. The trade was a 2.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider John Sheldon Peters sold 2,718 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $50.34, for a total value of $136,824.12. Following the sale, the insider directly owned 102,397 shares of the company’s stock, valued at $5,154,664.98. This represents a 2.59% decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,543 shares of company stock valued at $915,455 in the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

Lemonade Price Performance

Shares of LMND opened at $52.83 on Wednesday. Lemonade, Inc. has a one year low of $15.27 and a one year high of $60.41. The firm has a market capitalization of $3.90 billion, a P/E ratio of -18.67 and a beta of 2.27. The business has a fifty day moving average of $47.03 and a 200 day moving average of $38.30.

Lemonade (NYSE:LMND) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) EPS for the quarter, topping the consensus estimate of ($0.81) by $0.21. Lemonade had a negative return on equity of 36.12% and a negative net margin of 33.96%.The company had revenue of $164.10 million during the quarter, compared to analyst estimates of $160.88 million. During the same quarter in the previous year, the company posted ($0.81) earnings per share. Lemonade’s revenue was up 34.5% compared to the same quarter last year. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts expect that Lemonade, Inc. will post -3.03 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. BMO Capital Markets boosted their price target on Lemonade from $23.00 to $42.00 and gave the stock an “underperform” rating in a research note on Monday, August 18th. Cantor Fitzgerald upgraded Lemonade to a “strong-buy” rating in a research note on Wednesday, August 13th. Keefe, Bruyette & Woods restated an “underperform” rating and issued a $26.00 price target (up previously from $22.00) on shares of Lemonade in a research note on Tuesday, July 1st. Morgan Stanley restated an “underweight” rating on shares of Lemonade in a research note on Monday, August 18th. Finally, Piper Sandler restated a “neutral” rating and issued a $55.00 price target on shares of Lemonade in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, Lemonade has an average rating of “Reduce” and an average target price of $40.43.

Lemonade Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.